Concentra (CON) Q2 FY26 earnings call

The company delivered a strong second quarter, marked by robust revenue and EBITDA growth, driven by increased patient visits and higher revenue per visit across its occupational health centers. The business continues to execute on its strategy of expanding access through de novo development and disciplined acquisitions, while also achieving significant operational efficiencies and deleveraging ahead of schedule. The CEO transition to Matt DiCanio reflects continuity in strategy and leadership.